Heart Failure with Preserved Ejection Fraction: Concise Review.

Autor:	Sathyanarayanan SP; Department of Internal Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota., Oberoi M; Department of Internal Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota., Saad Shaukat MH; Department of Cardiology, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota., Stys T; Department of Cardiology, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota., Stys A; Department of Cardiology, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.; Cardiovascular Disease Fellowship Program, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Jazyk:	angličtina
Zdroj:	South Dakota medicine : the journal of the South Dakota State Medical Association [S D Med] 2022 Nov; Vol. 75 (11), pp. 513-517.
Abstrakt:	Heart failure with preserved ejection fraction (HFpEF) is a highly prevalent disease, causing a significant burden to the elderly population. Due to the inconsistencies in the standard definition and criteria for diagnosis, HFpEF is often underdiagnosed and left untreated. Although diastolic dysfunction is one of the key driving factors of the disease process, other factors like systolic limitations, endothelial dysfunction, arterial stiffness, and poor ventricular-arterial coupling are also contributing factors. While various treatment modalities have been investigated, the management continues to remain supportive. This review highlights the various American College of Cardiology/American Heart Association and European Society of Cardiology definitions, pathophysiology, and current treatment modalities available for HFpEF. (Copyright© South Dakota State Medical Association.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu